CAS: 30516-87-1 Zidovudine Powder

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
14
Year of Establishment
2017-02-08
  • CAS: 30516-87-1 Zidovudine Powder
  • CAS: 30516-87-1 Zidovudine Powder
  • CAS: 30516-87-1 Zidovudine Powder
  • CAS: 30516-87-1 Zidovudine Powder
  • CAS: 30516-87-1 Zidovudine Powder
  • CAS: 30516-87-1 Zidovudine Powder
Find Similar Products

Basic Info.

Model NO.
HNB-Zidovudine
Certification
GMP, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Powder
Purity
>99%
Product Name
Zidovudine
CAS
30516-87-1
Molecular Weight
267.241
Molecular Formula
C10h13n5o4
Density
/
Assay
HPLC99%
Sample
10g Available
Factory Supply
Yes
Usage
Animal Pharmaceuticals
Shelf Life
2 Years Proper Storage
Certificate
GMP/ISO9001
Packing
Carton Box or Drum
Payment
Tt/Western Union
Transport Package
Carton Box
Specification
HPLC 99%
Trademark
HNB
Origin
China
HS Code
3006920000
Production Capacity
1000kg Per Month

Product Description

CAS: 30516-87-1 Zidovudine Powder
Cas:30516-87-1 Zidovudine powder
 
product name Zidovudine
cas number 30516-87-1
apperance White powder
Density /
MF C10H13N5O4
MW 267.241

Zidovudine is an antiviral drug with a chemical formula of C10H13N5O4, used for the treatment of AIDS or AIDS-related syndromes and immunodeficiency virus (HIV) infection. On March 19, 1987, the US Food and Drug Administration approved the drug for marketing. Zidovudine is the world's first anti-AIDS drug approved by the US FDA. Because of its definite curative effect, it has become the most basic component of "cocktail" therapy. It is highly active against retroviruses including human immunodeficiency virus (HIV) in vitro. In virus-infected cells, it is phosphorylated by cellular thymidine kinase to zidovudine triphosphate, which can selectively inhibit HIV reverse transcriptase, leading to the termination of HIV chain synthesis and preventing HIV replication.
CAS: 30516-87-1 Zidovudine PowderPharmacological action
This product is an antiviral drug, which is highly active against retroviruses including human immunodeficiency virus (HIV) in vitro. In virus-infected cells, it is phosphorylated by cellular thymidine kinase to zidovudine triphosphate, which can selectively inhibit HIV reversal enzyme, leading to the termination of HIV chain synthesis and preventing HIV replication.

CAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine PowderCAS: 30516-87-1 Zidovudine Powder
CAS: 30516-87-1 Zidovudine Powder
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier